{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:23:25Z","timestamp":1792225405114,"version":"4.4.0"},"reference-count":38,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Cancers"],"abstract":"<jats:p>Ovarian cancer is the most lethal gynecological malignancy among women worldwide and is characterized by aggressiveness, cancer stemness, and frequent relapse due to resistance to platinum-based therapy. Ovarian cancer cells metastasize through ascites fluid as 3D spheroids which are more resistant to apoptosis and chemotherapeutic agents. However, the precise mechanism as an oncogenic addiction that makes 3D spheroids resistant to apoptosis and chemotherapeutic agents is not understood. To study the signaling addiction mechanism that occurs during cancer progression in patients, we developed an endometrioid subtype ovarian cancer cell line named \u2018MCW-OV-SL-3\u2019 from the ovary of a 70-year-old patient with stage 1A endometrioid adenocarcinoma of the ovary. We found that the cell line MCW-OV-SL-3 exhibits interstitial duplication of 1q (q21\u2013q42), where this duplication resulted in high expression of the PIK3C2B gene and aberrant activation of PI3K-AKT-ERK signaling. Using short tandem repeat (STR) analysis, we demonstrated that the cell line exhibits a unique genetic identity compared to existing ovarian cancer cell lines. Notably, the MCW-OV-SL-3 cell line was able to form 3D spheroids spontaneously, which is an inherent property of tumor cells when plated on cell culture dishes. Importantly, the tumor spheroids derived from the MCW-OV-SL-3 cell line expressed high levels of c-Kit, PROM1, ZEB1, SNAI, VIM, and Twist1 compared to 2D monolayer cells. We also observed that the hyperactivation of ERK and PI3K\/AKT signaling in these cancer cells resulted in resistance to cisplatin. In summary, the MCW-OV-SL3 endometrioid cell line is an excellent model to study the mechanism of cancer stemness and chemoresistance in endometrioid ovarian cancer.<\/jats:p>","DOI":"10.3390\/cancers14040958","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T22:43:22Z","timestamp":1644965002000},"page":"958","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5062-8950","authenticated-orcid":false,"given":"Deepak","family":"Parashar","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Geethadevi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Mittal","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-6774","authenticated-orcid":false,"given":"Lindsey","family":"McAlarnen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"George","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishaque","family":"Kadamberi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Uyar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hopp","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holli","family":"Drendel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Bishop","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bradley","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bone","sequence":"additional","affiliation":[{"name":"Department of Pathology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Rader","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunila","family":"Pradeep","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8268-3460","authenticated-orcid":false,"given":"Pradeep","family":"Chaluvally-Raghavan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"},{"name":"Cancer Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"ref_1","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2012.06.017","article-title":"DNA profiling analysis of endometrial and ovarian cell lines 789 reveals misidentification, redundancy and contamination","volume":"127","author":"Korch","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"dmm034199","DOI":"10.1242\/dmm.034199","article-title":"Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates","volume":"11","author":"Klymenko","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/156800910791190175","article-title":"Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer","volume":"10","author":"Ahmed","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","article-title":"Multicellular spheroids in ovarian cancer metastases: Biology and pathology","volume":"113","author":"Shield","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2147\/OTT.S187015","article-title":"Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2","volume":"12","author":"Yang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.18632\/genesandcancer.162","article-title":"ERBB signaling in CTCs of ovarian cancer and glioblastoma","volume":"8","author":"Geethadevi","year":"2017","journal-title":"Genes Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41388-020-1194-7","article-title":"ERBB3-induced furin promotes the progression and metastasis of ovarian cancer via the IGF1R\/STAT3 signaling axis","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Koshiyama, M., Matsumura, N., and Konishi, I. (2017). Subtypes of Ovarian Cancer and Ovarian Cancer Screening. Diagnostics, 7.","DOI":"10.3390\/diagnostics7010012"},{"key":"ref_12","first-page":"e50203","article-title":"Chromosome Preparation from Cultured Cells","volume":"83","author":"BHowe","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_13","first-page":"1","article-title":"An International System for Human Cytogenetic Nomenclature (1985) ISCN 1985. Report of the Standing Committee on Human Cytogenetic Nomenclature","volume":"21","year":"1985","journal-title":"Birth Defects Orig. Artic Ser."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000516654","article-title":"International System for Human Cytogenetic or Cytogenomic Nomenclature (ISCN): Some Thoughts","volume":"161","author":"Liehr","year":"2021","journal-title":"Cytogenet. Genome Res."},{"key":"ref_15","first-page":"1","article-title":"Targeted biologic inhibition of both tumor cell-intrinsic and intercellular CLPTM1L\/CRR9-mediated chemotherapeutic drug resistance","volume":"5","author":"Parashar","year":"2021","journal-title":"NPJ Precis. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-015-0258-y","article-title":"A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer","volume":"34","author":"Jagadish","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.celrep.2016.04.034","article-title":"Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer","volume":"15","author":"Jeong","year":"2016","journal-title":"Cell Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1158\/0008-5472.CAN-21-0483","article-title":"Chaluvally-Raghavan, On-costatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth","volume":"81","author":"Geethadevi","year":"2021","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1158\/1078-0432.CCR-17-0566","article-title":"Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma","volume":"23","author":"Depreeuw","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s00432-018-2737-y","article-title":"MiRNAs and their interplay with PI3K\/AKT\/mTOR pathway in ovarian cancer cells: A potential role in platinum resistance","volume":"144","author":"Gasparri","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"27220","DOI":"10.18632\/oncotarget.25513","article-title":"Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance","volume":"9","author":"Mevel","year":"2018","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1158\/1538-7445.AM2014-958","article-title":"Activation of COL11A1 by anticancer drugs through IGF-1R\/PI3K pathway confers chemoresistance in ovarian cancer via activating NF- kappa B-mediated Twist1 expression","volume":"74","author":"Wu","year":"2014","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1158\/0008-5472.CAN-19-3717","article-title":"Chaluvally-Raghavan, Peritoneal Spread of Ovarian Cancer Har-bors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR\/ERBB2 Signaling","volume":"80","author":"Parashar","year":"2020","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ccell.2014.10.010","article-title":"Copy Number Gain of hsa-miR-569 at 3q26.2 Leads to Loss of TP53INP1 and Aggressiveness of Epithelial Cancers","volume":"26","author":"Zhang","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.18632\/oncoscience.221","article-title":"Targeting ncRNAs in the 3q26.2 amplicon","volume":"2","author":"Mills","year":"2015","journal-title":"Oncoscience"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/onc.2011.547","article-title":"Modeling invasive breast cancer: Growth factors propel progression of HER2-positive premalignant lesions","volume":"31","author":"Pradeep","year":"2011","journal-title":"Oncogene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/j.celrep.2019.11.085","article-title":"miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer","volume":"29","author":"Parashar","year":"2019","journal-title":"Cell Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"109934","DOI":"10.1016\/j.celrep.2021.109934","article-title":"RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site","volume":"37","author":"George","year":"2021","journal-title":"Cell Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/geno.1994.1523","article-title":"Human and Mouse Chromosomal Mapping of the Myeloid Cell Leukemia-1 Gene: MCL1 Maps to Human Chromosome 1q21, a Region That Is Frequently Altered in Preneoplastic and Neoplastic Disease","volume":"23","author":"Craig","year":"1994","journal-title":"Genomics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/bjc.1997.304","article-title":"Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas","volume":"75","author":"Tapper","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-4608(97)00015-0","article-title":"A microsatellite within the MUC1 locus at 1q21 is altered in the neoplastic cells of breast cancer patients","volume":"100","author":"Waltz","year":"1998","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"ref_33","first-page":"489","article-title":"The phosphatidylinositol 3-Kinase\u2013AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1055\/s-0043-118907","article-title":"PI3K\/AKT\/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?","volume":"77","author":"Gasparri","year":"2017","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2015.02.003","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in ovarian cancer","volume":"137","author":"Mabuchi","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: An updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1040-8428(00)00076-7","article-title":"Contribution of three-dimensional culture to cancer research","volume":"36","author":"Desoize","year":"2000","journal-title":"Crit. Rev. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jbiotec.2010.01.012","article-title":"Multicellular tumor spheroids: An underestimated tool is catching up again","volume":"148","author":"Hirschhaeuser","year":"2010","journal-title":"J. Biotechnol."}],"updated-by":[{"DOI":"10.3390\/cancers14102443","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000}}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/4\/958\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T14:01:35Z","timestamp":1754229695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/4\/958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["cancers14040958"],"URL":"https:\/\/doi.org\/10.3390\/cancers14040958","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}